SOD2 and breast carcinoma: Association between MnSOD (SOD2) genotype and breast cancer recurrence among women who received cyclophosphamide-epirubicin-5-fluorouracil (CEF) adjuvant chemotherapy; women aged 35 to 69 years at breast cancer diagnosis who resided in Jutland, Denmark, 1991–2001.